Good news for the pharmaceutical equipment industry!

[ Policies and Regulations of Chemical Machinery and Equipment Network ] On January 28, the fiscal revenue and expenditure in 2020 was released.
Overall, in 2020, the national general public budget revenue was 18,289.
5 billion yuan, a year-on-year decrease of 3.
9%; the national general public budget expenditure was 2,455.
8 billion yuan, a year-on-year increase of 2.
8%.
It is worth mentioning that my country's tax and fee reduction efforts* in 2020 have played an important role.

 

It is reported that in 2020, my country has introduced and implemented 7 batches of 28 targeted tax and fee reduction measures to support the resumption of work and production of enterprises.
It is expected that the new burden of enterprises will be reduced by more than 2.
5 trillion yuan throughout the year.
Among them, small and micro enterprises have received key support from tax and fee reduction policies.
Statistics show that among the more than 50 million small-scale taxpayers across the country, nearly 90% are exempt from value-added tax.

　　"Tax reduction and fee reduction" can be said to be an accelerator for enterprise development, which can bring tangible benefits to enterprises.
The same is true in the pharmaceutical equipment industry.
Since the implementation of the tax and fee reduction policy in 2019, the tax reduction effect of domestic pharmaceutical equipment industry companies can be said to be obvious to all in the industry.
The sense of acquisition of pharmaceutical machinery companies has been significantly improved, including many small and medium-sized pharmaceutical machinery companies with the help of tax reductions.
The fee reduction "red envelope rain" climbed the slope smoothly and passed the hurdle.

 

　　In 2020, my country has further increased its tax and fee reduction efforts, and the policy of benefiting the people and enterprises will directly reach enterprises in the pharmaceutical equipment industry.
Canaan Technology issued an announcement on the evening of January 6, stating that Zhejiang Canaan Technology Co.
, Ltd.
and its holding subsidiaries received a total of 9.
2039 million yuan in subsidies from July 1, 2020 to December 31, 2020, including software The product value-added tax rebate subsidy fund is RMB 3.
5416 million, and other subsidy funds are RMB 5.
6623 million.

 

　　Chutian Technology announced in September 2020 that in accordance with the relevant provisions of the "Notice on Software Product Value-Added Tax Policies" of the two departments, general value-added taxpayers sell their own developed and produced software products (including embedded software) and add value to them If the actual tax burden exceeds 3%, a tax refund policy will be implemented.
After approval, the company recently received a partial value-added tax refund of RMB 6,215,100 for the actual tax burden of income from embedded software products exceeding 3%.

 

　　For pharmaceutical equipment companies, 2020 can be a year full of opportunities and challenges.
In the context of the rapid development of the pharmaceutical industry, pharmaceutical companies generate new demands and new requirements, and the requirements of the pharmaceutical equipment industry keep pace with the times, which also makes the industry The demand for talents inside has become more and more vigorous, and the demand for new products and new technologies has also begun to appear.
Under the policy of tax reduction and fee reduction, large pharmaceutical machinery companies have made great efforts to increase their efforts to concentrate on the introduction of corporate talents, research and development and innovation.
For example, Chutian Technology signed a modern apprenticeship development agreement with Yiyang Vocational and Technical College in December 2019.
According to the agreement, Yiyang Vocational and Technical College will aim at Chutian Technology’s human resource development needs, and carry out student-oriented training and on-the-job training or education qualifications through two methods, in-school oriented training and corporate oriented training, to cultivate high-quality in line with corporate development Laborers and technical talents.

 

　　In addition, it is currently in the age of transformation.
In recent years, domestic pharmaceutical equipment companies are actively trying to participate in the competition while meeting the domestic market demand.
The data shows that the average growth rate of the annual export delivery value of China's pharmaceutical equipment industry has reached 23.
075%.
From the perspective of the industry, tax cuts and fee reductions are conducive to pharmaceutical companies to reduce their corporate costs significantly, but also help companies to participate in competition, enhance the competitiveness of Chinese multinational companies, and help products better "go global.
"
 

　　It is reported that in 2021, my country will continue to promote tax and fee reduction policies, and continue to implement institutional tax and fee reduction policies such as deepening the reform of value-added tax and special additional deductions for personal income tax.
At the same time, continue to implement the inclusive tax reduction and exemption policy for small and micro enterprises.
This policy is undoubtedly good news for my country’s pharmaceutical equipment companies, especially small and medium-sized pharmaceutical companies.
Relevant companies should take advantage of the policy to actively increase investment in innovation, introduce high-level talents, and promote the development of the domestic pharmaceutical industry.
To develop in the direction of high-quality innovation, to cultivate a towering tree belonging to the pharmaceutical machinery economy, and to better participate in the competition.

 

　　Original title: Good news for the pharmaceutical equipment industry! In 2021, my country will continue to promote tax and fee reduction policies